Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Antibody-Dependent Cellular Cytoxicity (ADCC)-Mediating Antibodies

概要

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/762,543, entitled "Antibody-Dependent Cellular Cytoxicity (ADCC)- Mediating Antibodies," filed on February 8, 2013. The United States Government, as represented by the Secretary of the Army, has rights to this invention.